Sarepta Therapeutics (SRPT) Enters $40M At-The-Market Agreement with Citadel
Tweet Send to a Friend
Down)
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) filed a registration with the U.S. SEC to sell, from time to time, up to $40 million of its common stock.
The filing comes as Sarepta entered an at-the-market equity offering sales agreement with Citadel Securities LLC.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The filing comes as Sarepta entered an at-the-market equity offering sales agreement with Citadel Securities LLC.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- TCP Capital (TCPC) Prices Upsized 4.5M Common Stock Offering
- Cimatron (CIMT) Secondary Offering Priced at $6.25/Share
- Evolution Petroleum (EPM) Files $500M Mixed Shelf
Create E-mail Alert Related Categories
Corporate News, Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
